| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.695 | 0.009 | 0.695 | Angiogenesis inhibitor | |||
| 0.637 | 0.009 | 0.637 | Immunosuppressant | 0.615 0.011 CID_135923055 | ||
| 0.629 | 0.005 | 0.629 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.656 | 0.039 | 0.656 | Antiinflammatory | 0.423 0.125 CID_135923055 | ||
| 0.613 | 0.005 | 0.613 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.397 0.103 CID_135923055 | ||
| 0.502 | 0.024 | 0.502 | Aryl hydrocarbon receptor agonist | |||
| 0.411 | 0.002 | 0.411 | Dihydroorotase inhibitor | 0.166 0.004 CID_135923055 | ||
| 0.4 | 0.019 | 0.4 | Transcription factor STAT inhibitor | |||
| 0.394 | 0.018 | 0.394 | EphB2 antagonist | |||
| 0.343 | 0.004 | 0.343 | Nav1.8 sodium channel blocker | |||
| 0.332 | 0.005 | 0.332 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.334 | 0.007 | 0.334 | Sodium channel blocker | |||
| 0.406 | 0.087 | 0.406 | Cyclophilin D inhibitor | |||
| 0.327 | 0.015 | 0.327 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.319 | 0.012 | 0.319 | Growth factor agonist | 0.149 0.144 CID_135923055 | ||
| 0.296 | 0.005 | 0.296 | Raf kinase C inhibitor | |||
| 0.286 | 0.004 | 0.286 | TRPA1 antagonist | |||
| 0.275 | 0.009 | 0.275 | ATPase inhibitor | |||
| 0.266 | 0.012 | 0.266 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.339 | 0.092 | 0.339 | Calpain 2 inhibitor | |||
| 0.273 | 0.027 | 0.273 | Neurotrophic factor enhancer | 0.21 0.068 CID_135923055 | ||
| 0.246 | 0.006 | 0.246 | Stem cell growth factor agonist | |||
| 0.362 | 0.125 | 0.362 | Transcription factor inhibitor | 0.25 0.187 CID_135923055 | ||
| 0.27 | 0.038 | 0.27 | Neuropeptide Y2 antagonist | 0.227 0.08 CID_135923055 | ||
| 0.343 | 0.121 | 0.442 | 5 Hydroxytryptamine release inhibitor | 0.442 0.055 CID_135923055 | CID_135923055 | |
| 0.235 | 0.018 | 0.235 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.206 | 0.004 | 0.206 | Dihydroorotate dehydrogenase inhibitor | 0.162 0.005 CID_135923055 | ||
| 0.208 | 0.006 | 0.208 | Transcription factor STAT6 inhibitor | |||
| 0.347 | 0.148 | 0.347 | Caspase 9 stimulant | 0.318 0.174 CID_135923055 | ||
| 0.217 | 0.024 | 0.217 | Sodium channel (voltage-gated) blocker | |||
| 0.229 | 0.049 | 0.229 | Nitric-oxide synthase stimulant | |||
| 0.232 | 0.053 | 0.232 | MAP kinase kinase 3 inhibitor | |||
| 0.218 | 0.046 | 0.218 | Histone acetyltransferase inhibitor | |||
| 0.162 | 0.003 | 0.162 | Calcium release-activated channel blocker | |||
| 0.256 | 0.102 | 0.256 | Nootropic | |||
| 0.218 | 0.074 | 0.218 | Antimitotic | |||
| 0.288 | 0.148 | 0.288 | MAP kinase kinase 6 inhibitor | |||
| 0.182 | 0.044 | 0.182 | Vascular endothelial growth factor antagonist | |||
| 0.161 | 0.024 | 0.161 | Potassium channel (Ca-activated) activator | |||
| 0.175 | 0.041 | 0.175 | Vascular endothelial growth factor 2 antagonist | |||
| 0.136 | 0.005 | 0.136 | Glutamate (mGluR group III) agonist | |||
| 0.188 | 0.059 | 0.188 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.139 | 0.013 | 0.139 | Epoxide hydrolase inhibitor | |||
| 0.265 | 0.141 | 0.265 | GABA C receptor rho-3 antagonist | |||
| 0.142 | 0.023 | 0.142 | Interleukin 2 antagonist | |||
| 0.124 | 0.005 | 0.124 | Potassium channel (Tandem pore domain) blocker | |||
| 0.142 | 0.025 | 0.142 | Androgen antagonist | |||
| 0.15 | 0.039 | 0.15 | Death-associated protein kinase 1 inhibitor | |||
| 0.166 | 0.056 | 0.166 | Lck kinase inhibitor | |||
| 0.173 | 0.064 | 0.173 | Death-associated protein kinase 2 inhibitor | 0.143 0.122 CID_135923055 | ||
| 0.13 | 0.023 | 0.13 | Potassium channel (Voltage-sensitive) activator | |||
| 0.147 | 0.042 | 0.147 | Vascular endothelial growth factor 1 antagonist | |||
| 0.134 | 0.033 | 0.134 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.229 | 0.133 | 0.229 | Immunomodulator | 0.227 0.135 CID_135923055 | ||
| 0.105 | 0.011 | 0.105 | Aryl hydrocarbon receptor antagonist | |||
| 0.119 | 0.025 | 0.119 | Raf kinase inhibitor | |||
| 0.149 | 0.063 | 0.149 | Sphingosine 1-phosphate receptor 5 antagonist | 0.14 0.08 CID_135923055 | ||
| 0.099 | 0.019 | 0.099 | Secretase beta inhibitor | |||
| 0.162 | 0.083 | 0.162 | Tyrosine kinase inhibitor | |||
| 0.109 | 0.032 | 0.109 | Glutamate receptor agonist | |||
| 0.1 | 0.024 | 0.1 | Potassium channel large-conductance Ca-activated activator | |||
| 0.11 | 0.034 | 0.11 | Platelet growth factor antagonist | |||
| 0.104 | 0.034 | 0.104 | GABA A receptor agonist | |||
| 0.09 | 0.021 | 0.09 | Orexin receptor 1 antagonist | |||
| 0.118 | 0.05 | 0.118 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.122 | 0.054 | 0.122 | GABA receptor agonist | |||
| 0.088 | 0.02 | 0.088 | Orexin receptor antagonist | |||
| 0.118 | 0.057 | 0.118 | Nav1.5 sodium channel blocker | |||
| 0.074 | 0.014 | 0.228 | Dihydroorotate oxidase inhibitor | 0.228 0.002 CID_135923055 | CID_135923055 | |
| 0.104 | 0.044 | 0.104 | Potassium channel activator | |||
| 0.145 | 0.086 | 0.145 | CF transmembrane conductance regulator agonist | |||
| 0.076 | 0.021 | 0.076 | Bromodomain-containing protein 4 inhibitor | |||
| 0.066 | 0.016 | 0.066 | CXC chemokine 1 receptor antagonist | |||
| 0.096 | 0.059 | 0.096 | Bile acid receptor antagonist | |||
| 0.061 | 0.025 | 0.061 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.111 | 0.076 | 0.111 | Beta amyloid protein antagonist | |||
| 0.081 | 0.046 | 0.081 | Vanilloid antagonist | |||
| 0.233 | 0.199 | 0.233 | Analgesic | |||
| 0.05 | 0.016 | 0.05 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.07 | 0.036 | 0.07 | NMDA receptor agonist | |||
| 0.115 | 0.082 | 0.115 | Sphingosine 1-phosphate receptor 4 antagonist | 0.108 0.099 CID_135923055 | ||
| 0.057 | 0.024 | 0.057 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.053 | 0.021 | 0.053 | Benzodiazepine inverse agonist | |||
| 0.049 | 0.018 | 0.049 | Growth hormone secretagogue receptor antagonist | |||
| 0.072 | 0.042 | 0.072 | Vanilloid 1 antagonist | |||
| 0.054 | 0.025 | 0.054 | CC chemokine receptor 2B antagonist | |||
| 0.076 | 0.048 | 0.076 | Histone deacetylase stimulant | |||
| 0.076 | 0.048 | 0.076 | Histone deacetylase SIRT1 stimulant | |||
| 0.117 | 0.089 | 0.117 | Interleukin 4 antagonist | |||
| 0.096 | 0.068 | 0.096 | Insulin receptor antagonist | |||
| 0.05 | 0.024 | 0.05 | Stearoyl-CoA desaturase inhibitor | |||
| 0.033 | 0.008 | 0.033 | Glucosylceramidase stimulant | |||
| 0.063 | 0.038 | 0.063 | Raf kinase B inhibitor | |||
| 0.034 | 0.009 | 0.034 | Urotensin II antagonist | |||
| 0.084 | 0.059 | 0.084 | Bcr-Abl kinase inhibitor | |||
| 0.069 | 0.045 | 0.069 | Glutamate (mGluR7) antagonist | |||
| 0.103 | 0.081 | 0.103 | CDK3/cyclin E inhibitor | 0.098 0.092 CID_135923055 | ||
| 0.043 | 0.021 | 0.043 | Delayed rectifier potassium channel activator | |||
| 0.043 | 0.021 | 0.043 | Potassium channel KCNQ activator | |||
| 0.06 | 0.038 | 0.06 | Ca(v)3.2 blocker | |||
| 0.083 | 0.062 | 0.083 | Ca(v)2.2 blocker | |||
| 0.036 | 0.016 | 0.036 | Vanilloid 4 antagonist | |||
| 0.033 | 0.017 | 0.033 | Purinergic P2Y14 antagonist | |||
| 0.074 | 0.058 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.028 | 0.012 | 0.028 | Glutamate (mGluR1) agonist | |||
| 0.039 | 0.024 | 0.039 | Potassium channel Kv1.1 blocker | |||
| 0.091 | 0.077 | 0.091 | GABA C receptor agonist | |||
| 0.056 | 0.041 | 0.056 | Pregnane X receptor antagonist | |||
| 0.117 | 0.103 | 0.117 | Cyclooxygenase inhibitor | |||
| 0.049 | 0.035 | 0.049 | Bromodomain-containing protein 3 inhibitor | |||
| 0.032 | 0.019 | 0.032 | Potassium channel subfamily K member 3 blocker | |||
| 0.019 | 0.008 | 0.019 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.035 | 0.026 | 0.035 | Orexin receptor 2 antagonist | |||
| 0.026 | 0.019 | 0.026 | CXC chemokine 2 receptor antagonist | |||
| 0.041 | 0.035 | 0.041 | Neurokinin 3 antagonist | |||
| 0.056 | 0.05 | 0.056 | Purinergic P2X1 antagonist | |||
| 0.023 | 0.018 | 0.023 | Epoxide hydrolase 2 inhibitor | |||
| 0.056 | 0.052 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.052 | 0.048 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.046 | 0.042 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.231 | 0.228 | 0.352 | Calcium channel L-type activator | 0.352 0.116 CID_135923055 | CID_135923055 | |
| 0.115 | 0.112 | 0.115 | Src kinase inhibitor | |||
| 0.017 | 0.015 | 0.017 | Apolipoprotein B-100 inhibitor | |||
| 0.088 | 0.087 | 0.088 | Carbonic anhydrase XV inhibitor | |||
| 0.052 | 0.051 | 0.052 | Calcium channel T-type blocker | |||
| 0.127 | 0.135 | 0.132 | Ca2+-transporting ATPase inhibitor | 0.132 0.108 CID_135923055 | CID_135923055 | |
| 0.017 | 0.073 | 0.038 | Estrogen-related receptor alpha antagonist | 0.038 0.018 CID_135923055 | CID_135923055 | |
| 0.032 | 0.099 | 0.054 | Factor IXa inhibitor | 0.054 0.032 CID_135923055 | CID_135923055 | |
| 0.064 | 0.133 | 0.12 | Ferrochelatase inhibitor | 0.12 0.053 CID_135923055 | CID_135923055 | |
| 0.027 | 0.104 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.025 CID_135923055 | CID_135923055 | |
| 0.157 | 0.238 | 0.303 | Insulysin inhibitor | 0.303 0.057 CID_135923055 | CID_135923055 | |
| 0.032 | 0.136 | 0.088 | Catalase inhibitor | 0.088 0.043 CID_135923055 | CID_135923055 | |
| 0.065 | 0.181 | 0.146 | Alpha-N-acetylglucosaminidase inhibitor | 0.146 0.057 CID_135923055 | CID_135923055 | |
| 0.063 | 0.183 | 0.094 | Interleukin 12 antagonist | 0.094 0.065 CID_135923055 | CID_135923055 | |
| 0.025 | 0.157 | 0.037 | Leukotriene C4 antagonist | 0.037 0.032 CID_135923055 | CID_135923055 | |
| 0.038 | 0.171 | 0.061 | Leukotriene C antagonist | 0.061 0.027 CID_135923055 | CID_135923055 | |
| 0.031 | 0.174 | 0.052 | Factor III inhibitor | 0.052 0.03 CID_135923055 | CID_135923055 | |
| 0.043 | 0.204 | 0.119 | HIV-1 integrase (Overall Integration) inhibitor | 0.119 0.04 CID_135923055 | CID_135923055 | |
| 0.1 | 0.299 | 0.174 | Superoxide dismutase inhibitor | 0.174 0.15 CID_135923055 | CID_135923055 | |
| 0.071 | 0.282 | 0.254 | Polo-like kinase-3 inhibitor | 0.254 0.023 CID_135923055 | CID_135923055 | |
| 0.09 | 0.327 | 0.191 | Transcription factor NF kappa B inhibitor | 0.191 0.178 CID_135923055 | CID_135923055 | |
| 0.074 | 0.326 | 0.146 | Succinate dehydrogenase inhibitor | 0.146 0.121 CID_135923055 | CID_135923055 | |
| 0.11 | 0.382 | 0.271 | Histamine release inhibitor | 0.271 0.141 CID_135923055 | CID_135923055 | |
| 0.059 | 0.398 | 0.256 | Thioredoxin glutathione reductase inhibitor | 0.256 0.13 CID_135923055 | CID_135923055 | |
| 0.01 | 0.415 | 0.055 | Maillard reaction inhibitor | 0.055 0.039 CID_135923055 | CID_135923055 | |
| 0.084 | 0.568 | 0.251 | Peptidyltransferase inhibitor | 0.251 0.05 CID_135923055 | CID_135923055 | |
| 0.073 | 0.642 | 0.278 | Interleukin 2 agonist | 0.278 0.091 CID_135923055 | CID_135923055 | |
| 0.011 | 0.775 | 0.244 | Cell adhesion inhibitor | 0.244 0.016 CID_135923055 | CID_135923055 | |
| 0.005 | 0.8 | 0.063 | HIV-1 integrase inhibitor | 0.063 0.06 CID_135923055 | CID_135923055 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |